|
Mr. AN Lufan is the President and Chief Operation Officer (COO) of China Biopharmaceutical Holdings (CBH) and the CEO of Nanjing Keyuan Pharmaceutical Technology Corp. Prior to joining Nanjing Keyuan, Mr. An was the CEO of Shandon Tungtai Pharmaceutical Technology Corporation. Mr. An has an extensive experience in research and development and commercialization of new drugs. Mr. An has been involved in the development of at least thirty-two new drugs and published fifteen related articles in international journals. Mr. An graduated from Jining Medical College in 1985 with a B.S. degree in medicine and graduated from China Pharmaceutical University in 1991 with an M.S. degree in Pharmacology. | 